Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents-Reference-Cited by-同舟云学术

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents

Published:2014-09-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Otasowie John¹,Castells Xavier²,Ehimare Umonoibalo P³,Smith Clare H⁴

Affiliation:

1. Worcestershire Health and Care NHS Trust; Child and Family Service; Aconbury North Worcester UK WR5 1JG

2. Universitat de Girona; Unit of Clinical Pharmacology, TransLab Research Group, Department of Medical Sciences; Emili Grahit, 77 Girona Catalonia Spain 17071

3. Pathways Community Behavioral Health INC; 1800 Community Dr Clinton MI USA 64735-8808

4. Worcestershire Health and Care NHS Trust; Wyre Forest CAMHS, Kidderminster Health Centre; Bromsgrove Street Kidderminster Worcestershire UK DY10 1PG

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006997.pub2/fullpdf

Reference67 articles.

1. A double-blind placebo controlled study of desipramine in the treatment of ADD:1. Efficacy;Biederman;Journal of the American Academy of Child and Adolescent Psychiatry,1989

2. Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response;Donnelly;Clinical Pharmacology and Therapeutics,1986

3. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children;Garfinkel;Journal of the American Academy of Child Psychiatry,1983

4. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder;Prince;Journal of Child and Adolescent Psychopharmacology,2000

5. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine;Singer;Pediatrics,1995

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of adrenergic neurotransmitter reuptake inhibitors in the ADHD armamentarium;Expert Opinion on Pharmacotherapy;2024-05-23

2. New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms;Phytotherapy Research;2024-02-29

3. Are there links between Alzheimer’s disease and ADHD? The efficacy of acetylcholinesterase inhibitors and NMDA receptor antagonists in controlling ADHD symptoms: a systematic review;Middle East Current Psychiatry;2024-02-15

4. Efficacy, safety, and tolerability of serotonin-norepinephrine reuptake inhibitors in controlling ADHD symptoms: a systematic review and meta-analysis;Middle East Current Psychiatry;2024-01-31

5. Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder;Journal of Experimental Pharmacology;2024-01